TY - JOUR
T1 - Radioiodinated benzyloxybenzene derivatives
T2 - A class of flexible ligands target to β-amyloid plaques in Alzheimer's brains
AU - Yang, Yanping
AU - Cui, Mengchao
AU - Zhang, Xiaoyang
AU - Dai, Jiapei
AU - Zhang, Zhiyong
AU - Lin, Chunping
AU - Guo, Yuzhi
AU - Liu, Boli
PY - 2014/7/24
Y1 - 2014/7/24
N2 - Benzyloxybenzene, as a novel flexible scaffold without rigid planarity, was synthesized and evaluated as ligand toward Aβ plaques. The binding site calculated for these flexible ligands was the hydrophobic Val18-Phe20 channel on the flat surface of Aβ fiber. Structure-activity relationship analysis generated a common trend that binding affinities declined significantly from para-substituted ligands to ortho-substituted ones, which was also quantitatively illustrated by 3D-QSAR modeling. Autoradiography in vitro further confirmed the high affinities of radioiodinated ligands [125I]4, [125I]24, and [125I]22 (Ki = 24.3, 49.4, and 17.6 nM, respectively). In biodistribution, [125I]4 exhibited high initial uptake and rapid washout property in the brain with brain 2 min/brain60 min ratio of 16.3. The excellent in vitro and in vivo biostability of [125I]4 enhanced its potential for clinical application in SPECT imaging of Aβ plaques. This approach could also allow the design of a new generation of Aβ targeting ligands without rigid and planar framework.
AB - Benzyloxybenzene, as a novel flexible scaffold without rigid planarity, was synthesized and evaluated as ligand toward Aβ plaques. The binding site calculated for these flexible ligands was the hydrophobic Val18-Phe20 channel on the flat surface of Aβ fiber. Structure-activity relationship analysis generated a common trend that binding affinities declined significantly from para-substituted ligands to ortho-substituted ones, which was also quantitatively illustrated by 3D-QSAR modeling. Autoradiography in vitro further confirmed the high affinities of radioiodinated ligands [125I]4, [125I]24, and [125I]22 (Ki = 24.3, 49.4, and 17.6 nM, respectively). In biodistribution, [125I]4 exhibited high initial uptake and rapid washout property in the brain with brain 2 min/brain60 min ratio of 16.3. The excellent in vitro and in vivo biostability of [125I]4 enhanced its potential for clinical application in SPECT imaging of Aβ plaques. This approach could also allow the design of a new generation of Aβ targeting ligands without rigid and planar framework.
UR - http://www.scopus.com/inward/record.url?scp=84905046900&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84905046900&partnerID=8YFLogxK
U2 - 10.1021/jm5004396
DO - 10.1021/jm5004396
M3 - Article
C2 - 24936678
AN - SCOPUS:84905046900
SN - 0022-2623
VL - 57
SP - 6030
EP - 6042
JO - Journal of Medicinal Chemistry
JF - Journal of Medicinal Chemistry
IS - 14
ER -